PLGA Carriers for Controlled Release of Levofloxacin in Anti-Tuberculosis Therapy

Levofloxacin (LFX) is a highly effective anti-tuberculosis drug with a pronounced bactericidal activity against Mycobacterium tuberculosis (Mtb). In this work, an “organic solvent-free” approach has been used for the development of polylactic-co-glycolic acid (PLGA) microparticles and scaffolds cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonov, Evgeny N., Andreevskaya, Sofya N., Bocharova, Irina V., Bogorodsky, Sergei E., Krotova, Larisa I., Larionova, Elena E., Mariyanats, Alexandra O., Mishakov, Gennady V., Smirnova, Tatiana G., Chernousova, Larisa N., Popov, Vladimir K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227258/
https://www.ncbi.nlm.nih.gov/pubmed/35745846
http://dx.doi.org/10.3390/pharmaceutics14061275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227258/
https://www.ncbi.nlm.nih.gov/pubmed/35745846
http://dx.doi.org/10.3390/pharmaceutics14061275

Ejemplares similares